Martin & Co. Inc. TN Purchases Shares of 340,771 Viemed Healthcare, Inc. $VMD

Martin & Co. Inc. TN purchased a new stake in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 340,771 shares of the company’s stock, valued at approximately $3,885,000. Martin & Co. Inc. TN owned 0.89% of Viemed Healthcare as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently modified their holdings of VMD. BlackRock Inc. acquired a new stake in shares of Viemed Healthcare in the second quarter valued at $54,587,000. Arrowstreet Capital Limited Partnership grew its holdings in Viemed Healthcare by 101.9% during the first quarter. Arrowstreet Capital Limited Partnership now owns 711,186 shares of the company’s stock worth $6,550,000 after acquiring an additional 358,863 shares during the period. Tocqueville Asset Management L.P. acquired a new position in Viemed Healthcare during the second quarter worth about $3,900,000. Bard Associates Inc. bought a new stake in Viemed Healthcare in the second quarter worth about $3,872,000. Finally, Wasatch Advisors LP raised its position in Viemed Healthcare by 18.4% in the second quarter. Wasatch Advisors LP now owns 1,546,010 shares of the company’s stock worth $10,683,000 after acquiring an additional 240,346 shares in the last quarter. Institutional investors own 74.24% of the company’s stock.

Viemed Healthcare Stock Performance

Shares of VMD stock opened at $8.85 on Friday. The company has a market capitalization of $337.10 million, a price-to-earnings ratio of 24.58 and a beta of 1.10. Viemed Healthcare, Inc. has a 1-year low of $6.05 and a 1-year high of $12.61. The company has a current ratio of 1.13, a quick ratio of 1.02 and a debt-to-equity ratio of 0.04. The stock’s fifty day simple moving average is $10.98 and its 200-day simple moving average is $9.86.

Viemed Healthcare (NASDAQ:VMD) last announced its quarterly earnings data on Monday, August 3rd. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.05). Viemed Healthcare had a return on equity of 10.16% and a net margin of 4.81%.The business had revenue of $78.10 million during the quarter, compared to analysts’ expectations of $78.00 million. On average, sell-side analysts predict that Viemed Healthcare, Inc. will post 0.42 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Viemed Healthcare news, Director Timothy Smokoff sold 20,000 shares of the company’s stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $11.50, for a total value of $230,000.00. Following the transaction, the director owned 75,518 shares in the company, valued at approximately $868,457. This represents a 20.94% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider William Frazier sold 10,000 shares of the stock in a transaction that occurred on Thursday, June 25th. The stock was sold at an average price of $11.72, for a total transaction of $117,200.00. Following the completion of the sale, the insider owned 73,214 shares of the company’s stock, valued at approximately $858,068.08. The trade was a 12.02% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 20.60% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the stock. Wall Street Zen lowered shares of Viemed Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 15th. Weiss Ratings downgraded shares of Viemed Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, August 17th. Finally, Freedom Capital lowered shares of Viemed Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 5th. Three investment analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the company has a consensus rating of “Hold”.

About Viemed Healthcare

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.